对话分析
宏观分析
个别股票
Alpha 实验室
实用工具
Menu
ZH
登录
ZH
暴跌分析
/
Aspire Biopharma Holdings Inc.
/
2026-04-16
▼ PLUNGE
Aspire Biopharma Holdings Inc.
-45.0%
ASBP
NASDAQ
Healthcare
2026-04-16
0.3
收盘价
0.545
前收盘价
-44.95%
涨幅
4.4x
量比
暴跌原因
2026년 4월 15일, Aspire Biopharma는 DCS Unit 인수를 위한 투자의향서(LOI)를 체결했습니다.
·
2026년 4월 15일, Aspire Biopharma는 DCS Unit 인수를 위한 투자의향서(LOI)를 체결했습니다.
相关新闻
Aspire Biopharma Signs LOI to Acquire DCS Unit
Tipranks
2026-04-15
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
Marketwatch
2026-04-13
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
Marketwatch
2026-04-09
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
Marketwatch
2026-03-26
Osteopore Issues Additional Unquoted Convertible Notes
Tipranks
2026-02-06
技术分析
信号
布林下轨突破
超卖
MACD看跌
跌破SMA20
关键指标
29.68
RSI (14)
0.94
SMA 20
0.47
Bollinger Lower
1.42
Bollinger Upper
0.94
Bollinger Mid
-0.10
MACD
-0.05
MACD Signal
-0.04
MACD Hist
查看股票详情
返回暴涨股列表
Aspire Biopharma Holdings Inc. +-45.0% 暴涨分析 (2026-04-16) | Alpha Lenz